568 related articles for article (PubMed ID: 17440054)
1. GRP78 induction in cancer: therapeutic and prognostic implications.
Lee AS
Cancer Res; 2007 Apr; 67(8):3496-9. PubMed ID: 17440054
[TBL] [Abstract][Full Text] [Related]
2. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
3. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.
Dong D; Ni M; Li J; Xiong S; Ye W; Virrey JJ; Mao C; Ye R; Wang M; Pen L; Dubeau L; Groshen S; Hofman FM; Lee AS
Cancer Res; 2008 Jan; 68(2):498-505. PubMed ID: 18199545
[TBL] [Abstract][Full Text] [Related]
4. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.
Daneshmand S; Quek ML; Lin E; Lee C; Cote RJ; Hawes D; Cai J; Groshen S; Lieskovsky G; Skinner DG; Lee AS; Pinski J
Hum Pathol; 2007 Oct; 38(10):1547-52. PubMed ID: 17640713
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance.
Wang Q; He Z; Zhang J; Wang Y; Wang T; Tong S; Wang L; Wang S; Chen Y
Cancer Detect Prev; 2005; 29(6):544-51. PubMed ID: 16297569
[TBL] [Abstract][Full Text] [Related]
6. Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance.
Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Yoshimastu T; Morita M; Yasumoto K
Lung Cancer; 2005 Jul; 49(1):55-62. PubMed ID: 15949590
[TBL] [Abstract][Full Text] [Related]
7. Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment.
Dong D; Ko B; Baumeister P; Swenson S; Costa F; Markland F; Stiles C; Patterson JB; Bates SE; Lee AS
Cancer Res; 2005 Jul; 65(13):5785-91. PubMed ID: 15994954
[TBL] [Abstract][Full Text] [Related]
8. Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo.
Gazit G; Kane SE; Nichols P; Lee AS
Cancer Res; 1995 Apr; 55(8):1660-3. PubMed ID: 7712471
[TBL] [Abstract][Full Text] [Related]
9. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
11. VP-16 resistance in the NCI-H460 human lung cancer cell line is significantly associated with glucose-regulated protein78 (GRP78) induction.
Wang Q; Wang T; Wang Y; Wang W; Wang Y; Hu X; Shao S; Zhang J; Suo Z
Anticancer Res; 2007; 27(4B):2359-64. PubMed ID: 17695526
[TBL] [Abstract][Full Text] [Related]
12. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
[TBL] [Abstract][Full Text] [Related]
13. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.
Arap MA; Lahdenranta J; Mintz PJ; Hajitou A; Sarkis AS; Arap W; Pasqualini R
Cancer Cell; 2004 Sep; 6(3):275-84. PubMed ID: 15380518
[TBL] [Abstract][Full Text] [Related]
14. GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis.
Shu CW; Sun FC; Cho JH; Lin CC; Liu PF; Chen PY; Chang MD; Fu HW; Lai YK
J Cell Physiol; 2008 Jun; 215(3):627-35. PubMed ID: 18064632
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of molecular chaperone 78-kd glucose-regulated protein/immunoglobulin-binding protein expression involved in enhancement of human RS cell mutability.
Hirano J; Kita K; Sugaya S; Ichimura Y; Yamamori H; Nakajima N; Suzuki N
Pancreas; 2008 Jan; 36(1):e7-14. PubMed ID: 18192872
[TBL] [Abstract][Full Text] [Related]
16. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
[TBL] [Abstract][Full Text] [Related]
17. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486
[TBL] [Abstract][Full Text] [Related]
18. GRP78 signaling hub a receptor for targeted tumor therapy.
Sato M; Yao VJ; Arap W; Pasqualini R
Adv Genet; 2010; 69():97-114. PubMed ID: 20807604
[TBL] [Abstract][Full Text] [Related]
19. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
Lee E; Nichols P; Spicer D; Groshen S; Yu MC; Lee AS
Cancer Res; 2006 Aug; 66(16):7849-53. PubMed ID: 16912156
[TBL] [Abstract][Full Text] [Related]
20. Glucose-deprived HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator.
Park HR; Ryoo IJ; Choo SJ; Hwang JH; Kim JY; Cha MR; Shin-Ya K; Yoo ID
Toxicology; 2007 Jan; 229(3):253-61. PubMed ID: 17161515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
